Tag Archives: blood eosinophil levels may help inform COPD treatment decisions

GSK presented data at European Respiratory Society Congress that show blood eosinophil levels may help inform COPD treatment decisions

Posted on 10, September 2014 by

LONDON, 10-9-2014 — /EuropaWire/ — GSK today presented data at the European Respiratory Society (ERS) Congress that show blood eosinophil levels may help predict those patients with COPD who will have a greater reduction in exacerbation rates when receiving an … Read the full press release →

Posted in Healthcare, Pharma & Biotech, United Kingdom

Tagged , ,